9-27543384-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000645861.1(EMICERI):​n.8082C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.782 in 152,160 control chromosomes in the GnomAD database, including 46,652 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.78 ( 46648 hom., cov: 32)
Exomes 𝑓: 0.83 ( 4 hom. )

Consequence

EMICERI
ENST00000645861.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.37

Publications

29 publications found
Variant links:
Genes affected
EMICERI (HGNC:53656): (EQTN MOB3B IFNK C9orf72 enhancer RNA I)
C9orf72 (HGNC:28337): (C9orf72-SMCR8 complex subunit) The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]
C9orf72 Gene-Disease associations (from GenCC):
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.883 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000645861.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EMICERI
ENST00000645861.1
n.8082C>T
non_coding_transcript_exon
Exon 2 of 2
C9orf72
ENST00000673600.1
n.*267+4731G>A
intron
N/AENSP00000500650.1

Frequencies

GnomAD3 genomes
AF:
0.782
AC:
118871
AN:
152030
Hom.:
46616
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.762
Gnomad AMI
AF:
0.733
Gnomad AMR
AF:
0.823
Gnomad ASJ
AF:
0.799
Gnomad EAS
AF:
0.905
Gnomad SAS
AF:
0.825
Gnomad FIN
AF:
0.838
Gnomad MID
AF:
0.726
Gnomad NFE
AF:
0.764
Gnomad OTH
AF:
0.774
GnomAD4 exome
AF:
0.833
AC:
10
AN:
12
Hom.:
4
Cov.:
0
AF XY:
0.800
AC XY:
8
AN XY:
10
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
1.00
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.833
AC:
5
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.750
AC:
3
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.782
AC:
118954
AN:
152148
Hom.:
46648
Cov.:
32
AF XY:
0.785
AC XY:
58420
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.762
AC:
31609
AN:
41496
American (AMR)
AF:
0.824
AC:
12593
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.799
AC:
2773
AN:
3470
East Asian (EAS)
AF:
0.905
AC:
4690
AN:
5182
South Asian (SAS)
AF:
0.824
AC:
3972
AN:
4820
European-Finnish (FIN)
AF:
0.838
AC:
8869
AN:
10578
Middle Eastern (MID)
AF:
0.726
AC:
212
AN:
292
European-Non Finnish (NFE)
AF:
0.764
AC:
51934
AN:
68002
Other (OTH)
AF:
0.776
AC:
1635
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1341
2681
4022
5362
6703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.773
Hom.:
78068
Bravo
AF:
0.782
Asia WGS
AF:
0.854
AC:
2968
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.47
DANN
Benign
0.74
PhyloP100
-1.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3849943; hg19: chr9-27543382; API